THE UNIVERSITY OF QUEENSLAND

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1909-01-01

Employees: 5K

Market Cap: -

Website: http://www.uq.edu.au

Clinical Trials

SPINEPASS: SPINE Self-management Techniques for Persistent Headache After Concussion: Physical Therapy Targeting Autonomic and Dura Mater Function.

Not Applicable

Not yet recruiting

Conditions: Persistent Post-concussive Symptoms
Post Traumatic Headache

First Posted Date: 2025-03-18

Last Posted Date: 2025-03-18

Lead Sponsor: The University of Queensland

Target Recruit Count: 120

Registration Number: NCT06882239

Locations: 🇺🇸
Brook Army Medical Center, San Antonio, Texas, United States

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Not Applicable

Not yet recruiting

Conditions: Blood Culture Contamination
Infection

First Posted Date: 2025-02-04

Last Posted Date: 2025-02-12

Lead Sponsor: The University of Queensland

Target Recruit Count: 1148

Registration Number: NCT06806709

Locations: 🇦🇺
Caboolture Hospital, Caboolture, Queensland, Australia
🇦🇺
Redcliffe Hospital, Redcliffe, Queensland, Australia
🇦🇺
The Gold Coast University Hospital, Southport, Queensland, Australia

STarting incrEmental Prescription of Peritoneal Dialysis

Not Applicable

Not yet recruiting

Conditions: Peritoneal Dialysis (PD)
Kidney Failure

First Posted Date: 2024-10-15

Last Posted Date: 2024-10-15

Lead Sponsor: The University of Queensland

Target Recruit Count: 224

Registration Number: NCT06642597

Locations: 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer

Phase 2

Not yet recruiting

Conditions: Haematological Malignancy
Blood Cancer
Infectious Disease
Fungal Infection

Interventions: Other: genotype-directed dosing with dosing software based on therapeutic drug monitoring

First Posted Date: 2024-07-19

Last Posted Date: 2024-07-19

Lead Sponsor: The University of Queensland

Target Recruit Count: 104

Registration Number: NCT06510699

Locations: 🇦🇺
Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia
🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇦🇺
Sydney Children's Hospital Network, Sydney, New South Wales, Australia

and more 4 locations

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside

Not Applicable

Not yet recruiting

Conditions: Ataxia Telangiectasia

Interventions: Drug: Nicotinamide riboside

First Posted Date: 2024-03-22

Last Posted Date: 2024-04-18

Lead Sponsor: The University of Queensland

Target Recruit Count: 10

Registration Number: NCT06324877

Locations: 🇦🇺
Queensland Children's Hospital, Brisbane, Queensland, Australia

REmission in Membranous Nephropathy International Trial (REMIT)

Phase 3

Not yet recruiting

Conditions: Primary Membranous Nephropathy

Interventions: Drug: Oral prednisolone and cyclophosphamide
Drug: Obinutuzumab

First Posted Date: 2023-11-07

Last Posted Date: 2023-11-07

Lead Sponsor: The University of Queensland

Target Recruit Count: 224

Registration Number: NCT06120673

Locations: 🇦🇺
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
🇦🇺
Cairns Hospital, Cairns, Queensland, Australia
🇦🇺
Fiona Stanley Hospital, Murdoch, Western Australia, Australia

and more 10 locations

Mind-body Therapies for Injury-related Pain Management in Elite Athletes

Not Applicable

Withdrawn

Conditions: Pain, Acute

Interventions: Behavioral: Mindfulness Meditation
Behavioral: Clinical Hypnosis

First Posted Date: 2023-10-23

Last Posted Date: 2024-07-10

Lead Sponsor: The University of Queensland

Registration Number: NCT06095687

Locations: 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia

iToBoS Prospective Data Acquisition and Feasibility Study (Barcelona)

Recruiting

Conditions: Skin Cancer

First Posted Date: 2023-07-21

Last Posted Date: 2024-06-25

Lead Sponsor: The University of Queensland

Target Recruit Count: 350

Registration Number: NCT05955443

Locations: 🇪🇸
Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain

A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.

Phase 1

Completed

Conditions: COVID-19

Interventions: Biological: NVX-CoV2373 vaccine
Biological: UQSC2 Vaccine

First Posted Date: 2023-03-20

Last Posted Date: 2024-03-06

Lead Sponsor: The University of Queensland

Target Recruit Count: 70

Registration Number: NCT05775887

Locations: 🇦🇺
QPharm Pty.Ltd. (Nucleus Network Brisbane), Herston, Queensland, Australia

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)

Not Applicable

Recruiting

Conditions: Catheter Infection
Vascular Access Complication
Device Related Sepsis
Catheter Complications
Wound of Skin
Device Related Infection
Catheter Related Complication
Wound
Occlusive Dressings
Device Site Reactions

Interventions: Device: Standard bordered polyurethane dressing
Device: Chlorhexidine gluconate impregnated bordered polyurethane dressing

First Posted Date: 2023-02-23

Last Posted Date: 2023-08-21

Lead Sponsor: The University of Queensland

Target Recruit Count: 300

Registration Number: NCT05741866

Locations: 🇦🇺
Queensland Children's Hospital, South Brisbane, Queensland, Australia
🇦🇺
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
🇫🇷
University Hospital of Poitiers, Poitiers, Nouvelle-Aquitaine, France

Home Terms & Conditions Privacy Policy